GSK shares leap 5% as results top forecasts and guidance is …

GSK Shares Leap 5% As Results Top Forecasts And Guidance Is …

2 weeks from now

3 days ago  · Image source: Getty images. GSK shares ended 2024 on a sour note after what proved to be a rollercoaster year.. The pharma giant dropped 7% over the 12 months, as …

yahoo.com

GSK Shares Leap 5% As Results Top Forecasts And Guidance Is ... - MSN

2 weeks from now

Strong full-year trading and an improving outlook have propelled GSK's share price higher, as Royston Wild explains. The post GSK shares leap 5% as results top forecasts and guidance is …

msn.com

GSK Delivers Strong 2024 Performance With Further Improvement …

2 weeks from now

3 days ago  · £2 billion share buyback programme to be implemented over the next 18 months; 2025 guidance and further improvement to long-term outlooks. Expect 2025 turnover growth of …

gsk.com

FTSE 100 Live 05 February: GSK Shares Surge On New Guidance, …

2 weeks from now

The confidence in GSK’s drugs pipeline came alongside results pointing to top line growth between 3% and 5% in 2025. Mining stocks also rallied today after the price of gold set …

msn.com

GSK Boosts Long-term Sales Target As 2024 Revenue Beats …

2 weeks from now

3 days ago  · GSK maintained its final quarter dividend at 16 pence per share. Its annual dividend of 61p is up 5.2% from 58p for 2023. For this year, it expects a total payout of 65p per share. …

marketscreener.com

GSK Shares Rise Over 5% After Q4 Results - MSN

2 weeks from now

The stock's 5.65% gain suggests the market is focusing on the company's strong sales growth and positive guidance. GSK will host a conference call at 10:45 am GMT to discuss the results …

msn.com

GSK Ups Five-year Sales Outlook, But 2024 Results Come Up Short

2 weeks from now

3 days ago  · The top-line results came in slightly short of the £32bn expected by analysts, while core earnings per share rose 3% to 159.3p, missing the 163.9p consensus estimate.

lse.co.uk

GSK Launches $2.5 Billion Buyback, Lifts Sales Target After Stellar ...

2 weeks from now

3 days ago  · GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and …

reuters.com

GSK Lags Q4 Earnings, Tops Sales, Issues Upbeat '24 Guidance

2 weeks from now

Jan 31, 2024  · 2024 Guidance. GSK issued its guidance for 2024. The company expects sales to increase 5% to 7% in 2024. ... GSK’s Q4 results were mixed, as it beat estimates for sales but …

nasdaq.com

GSK Ups Long-term Guidance On New Drug Hopes

2 weeks from now

3 days ago  · GSK updated its long-term forecast alongside announcing financial results for 2024, which saw overall sales increase 3% to £31.4 billion, although the figure was pegged back by …

firstwordpharma.com

Strong Performance And Momentum Drive Upgraded Guidance - GSK

2 weeks from now

Jul 26, 2023  · 2023 guidance upgraded, Q2 2023 dividend of 14p declared, 56.5p expected for full year ... (from 12-15%) Guidance all at CER and excluding COVID-19 solutions. Emma …

gsk.com

GSK Lifts Guidance After HIV, Cancer Treatments Boost Sales

2 weeks from now

GSK Lifts Guidance After HIV, Cancer Treatments Boost Sales ... sales growth of 7% to 9% this year compared to a previous forecast in the upper range of 5% to 7%. ... per share, GSK …

wsj.com

GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion …

2 weeks from now

3 days ago  · Wednesday, GSK Plc (NYSE:GSK) reported fourth-quarter sales of $10.40 billion (8.12 billion Sterling Pounds), up 1% year-over-year and up 4% on constant currency. The …

yahoo.com

GSK Surges After Bumping Its 2031 Outlook To North Of $50 Billion

2 weeks from now

2 days ago  · For the year, GSK guided to 3% to 5% sales growth. The company also projects core earnings growth of 6% to 8%. Analysts forecast earnings of $4.54 a share and $42.64 billion in …

investors.com

The GSK Share Price Jumps 6% On Positive FY 2024 Results. Is

2 weeks from now

3 days ago  · The GSK share price rallied 6% this morning after the company published a surprisingly strong set of full-year results for 2024. Many metrics beat analysts’ expectations, including sales and ...

fool.co.uk

Stockwatch: A Better 2025 For GSK, Or Best To Sell Now?

2 weeks from now

Jan 3, 2025  · GSK’s share price did rally 25% to over 1,800p in the first half of 2024, but had plunged towards 1,300p by mid-November. ... GSK’s third-quarter 2024 results re-affirmed …

ii.co.uk

3 Key FTSE 100 Stock Updates To Watch For In January

2 weeks from now

Jan 2, 2025  · The GSK share price jumps 6% on positive FY 2024 results. Is it a stock to consider now? ... GSK shares leap 5% as results top forecasts and guidance is upgraded! Can they …

fool.co.uk

GSK Ups Five-year Sales Outlook, Unveils $2bn Buyback

2 weeks from now

3 days ago  · The top-line results came in slightly short of the £32bn expected by analysts, while core earnings per share rose 3% to 159.3p, missing the 163.9p consensus estimate.

sharecast.com

The GSK Share Price Jumps 6% On Positive FY 2024 Results. Is It A

2 weeks from now

The GSK share price rallied 6% this morning after the company published a surprisingly strong set of full-year results for 2024. Many metrics beat analysts’ expectations, including sales and ...

msn.com

GSK Issues $2.5 Billion Buyback, Raises Midterm Outlook After …

2 weeks from now

3 days ago  · By Helena Smolak . GSK plans to buy back $2.50 billion in shares and raised its midterm sales target, citing promising pipeline developments. The British pharmaceutical giant …

morningstar.com

GSK Is Emerging From Its Long Convalescence - Financial Times

2 weeks from now

2 days ago  · True, GSK’s shares rose almost 7 per cent on Wednesday but this probably had much to do with the unexpected announcement of a £2bn share buyback, the company’s first …

ft.com